Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum

Core Insights - Abeona Therapeutics Inc. is participating in a virtual fireside chat at the Stifel Virtual Cell Therapy Forum on July 9, 2024, at 9:45 a.m. Eastern Time [1] - The company is focused on developing cell and gene therapies for serious diseases, including its investigational product pz-cel for recessive dystrophic epidermolysis bullosa [2] Company Overview - Abeona Therapeutics is a clinical-stage biopharmaceutical company specializing in cell and gene therapies [2] - The company has a fully integrated cGMP manufacturing facility that supports the production of pz-cel for its Phase 3 VIITAL™ trial and potential commercial production upon FDA approval [2] - Abeona is also developing AAV-based gene therapies targeting ophthalmic diseases with high unmet medical needs, utilizing next-generation AAV capsids to enhance tropism profiles [2]